In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Safe and sound dosing program. Extra members will be enrolled on the determined monotherapy dosign program. In Phase B, participants will receive oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section https://charlesq887blw0.daneblogger.com/profile